对脊髓脊膜膨出患者采用无菌一次性与重复使用聚氯乙烯导尿管进行清洁间歇导尿的随机临床试验:短期尿路感染结局
这项两臂随机平行临床试验于2015至2016年在本中心纳入83例脊髓脊膜膨出所致神经源性膀胱患者,随机分为一次性与重复使用聚氯乙烯导尿管组,随访8周。结果显示两组无症状菌尿(32.4% vs 23.7%,p=0.398)与尿路感染(35.2% vs 36.8%,p=0.877)频率均无统计学差异。结论认为一次性导尿管未降低尿路感染发生率,与2014年Cochrane综述一致。
要点
- 一次性与重复使用聚氯乙烯导尿管组尿路感染频率分别为35.2%与36.8%,无统计学差异(p=0.877)。
- 两组无症状菌尿频率分别为32.4%与23.7%,无统计学差异(p=0.398)。
- 脊髓脊膜膨出神经源性膀胱患者中,一次性导尿管未降低短期尿路感染发生率。
核心结论
- 在脊髓脊膜膨出所致神经源性膀胱患者中,一次性聚氯乙烯导尿管间歇导尿与重复使用聚氯乙烯导尿管相比未降低尿路感染发生率,结果与2014年Cochrane综述一致。
研究设计与样本
- 两臂随机平行临床试验,2015至2016年在本中心开展,随访8周。
- 纳入标准为年龄2岁及以上、诊断为脊髓脊膜膨出并规律行清洁间歇导尿、初次评估时无尿路感染。
- 共筛查135例,随机化83例,完成随访75例;平均年龄12.7岁(范围2-56),男性29例、女性46例。
- 患者分为一次性聚氯乙烯导尿管组与重复使用聚氯乙烯导尿管组,于第0、7、14、28、42、56天进行评估。
- 主要结局为尿路感染频率,定义为尿培养阳性并伴发热、腰痛、不适或尿液浑浊/异味。
主要发现
- 一次性导尿管组与重复使用导尿管组无症状菌尿频率分别为32.4%与23.7%,p=0.398。
- 一次性导尿管组与重复使用导尿管组尿路感染频率分别为35.2%与36.8%,p=0.877。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Urinary tract infections are common and severe complications in patients with spina bifida. Management includes intermittent bladder catheterization with single use or reused sterile catheters. There is insufficient evidence to set a standard among the different techniques. We determined whether single use polyvinylchloride catheters would reduce urinary tract infections compared to reused polyvinylchloride catheters in patients with neurogenic bladder due to spina bifida. MATERIALS AND METHODS: We performed a 2-arm randomized parallel clinical trial from 2015 to 2016 with an 8-week followup at our center in patients with neurogenic bladder caused by spina bifida. Patients were divided into single use and reused polyvinylchloride catheter groups. Evaluations were done on days 0, 7, 14, 28, 42 and 56. Participants reported symptoms and urine cultures were obtained. The primary outcome was urinary tract infection frequency, defined as positive urine culture plus fever, flank pain, malaise, or cloudy or odorous urine. Study eligibility criteria were age 2 years or greater, spina bifida diagnosis with regular clean intermittent bladder catheterization and no urinary tract infection at initial evaluation. RESULTS: The calculated sample size was 75. Of the patients 135 were screened, 83 were randomized and 75 completed followup. Mean age was 12.7 years (range 2-56) and there were 29 males and 46 females. No statistical difference was found between the single use vs reused catheter groups in the frequency of asymptomatic bacteriuria (32.4% vs 23.7%, p = 0.398) or urinary tract infections (35.2% vs 36.8%, p = 0.877). CONCLUSIONS: Single use polyvinylchloride catheters for intermittent bladder catheterization did not decrease the incidence of urinary tract infections in our patients with neurogenic bladder compared to reused polyvinylchloride catheters. These results are consistent with the 2014 Cochrane Review.
引用
- Madero-Morales PA, Robles-Torres JI, Vizcarra-Mata G, et al. Randomized Clinical Trial Using Sterile Single Use and Reused Polyvinylchloride Catheters for Intermittent Catheterization with a Clean Technique in Spina Bifida Cases: Short-Term Urinary Tract Infection Outcomes. J Urol. 2019. PMID: 30916625. doi:10.1097/JU.0000000000000244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。